Pancreatic Cancer Immunotherapy works by activating T cells that recognize tumor-specific antigens. Immunotherapy of pancreatic cancer categorised into adjuvant immunotherapies, adoptive T cell transfer, cytokines, checkpoint inhibitors/immune modulators, monoclonal antibodies, therapeutic vaccines.
Immunotherapy is beneficial by causing minimal side effects, alternative to conventional treatment. Pancreatic Cancer is known as one of the most lethal cancer however Immune - based strategies have been evolved to treat pancreatic cancer.
Related Journals of Pancreatic Cancer Immunotherapy
Immunotherapy: Open Access, Immunooncology journal, Immunome Research journal, Immunology Journal, Immunobiology journal, Therapeutic Advances in Medical Oncology, Journal of Immunology Research, Biomed Research International, Journal of Immunotherapy of Cancer, Nature Reviews Cancer.